Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma

Rebecca V. Steenaard*, Marjolein N. T. Kremers, Laura A. Michon, Myrte Zijlstra, Harm R. Haak

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Little is known about the impact of adrenocortical carcinoma (ACC) on health-related quality of life (HRQoL), and no disease-specific questionnaire exists. This qualitative study aimed to identify relevant domains of HRQoL for patients with ACC.

In 2 focus group interviews, we discussed concerns regarding living with ACC and its treatments. The first group consisted of 6 patients on mitotane therapy and their partners or relatives, the second group of 4 patients after surgery alone and their partners. Inductive qualitative content analysis was used to analyze the interviews.

We identified 4 domains related to HRQoL in patients with ACC, namely physical complaints, mental consequences, social consequences, and functional limitations. For example, physical complaints included symptoms of the disease and side effects of mitotane therapy; mental consequences included feeling insecure and living from scan to scan; and functional limitations included daily activities and mobility. We further found that patients' experiences with the health care system and health care professionals and partner perspectives influence HRQoL.

In conclusion, ACC has a large impact on HRQoL in 4 domains. These results can be used to improve communication about HRQoL issues. We will use our findings to generate a disease-specific questionnaire to measure HRQoL in patients with ACC. (C) Endocrine Society 2020.

Original languageEnglish
Article number040
Number of pages9
JournalJournal of the endocrine society
Issue number5
Publication statusPublished - May 2020


  • adrenocortical carcinoma
  • health-related quality of life
  • patient experiences
  • partner perspectives
  • adrenalectomy
  • mitotane therapy
  • CARE


Dive into the research topics of 'Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma'. Together they form a unique fingerprint.

Cite this